Artivion Debt to Equity Ratio 2010-2022 | AORT

Current and historical debt to equity ratio values for Artivion (AORT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Artivion debt/equity for the three months ending September 30, 2022 was 1.22.
Artivion Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2022-09-30 $0.49B $0.26B 1.91
2022-06-30 $0.48B $0.28B 1.72
2022-03-31 $0.48B $0.30B 1.63
2021-12-31 $0.49B $0.30B 1.64
2021-09-30 $0.51B $0.31B 1.63
2021-06-30 $0.51B $0.30B 1.69
2021-03-31 $0.50B $0.30B 1.67
2020-12-31 $0.46B $0.33B 1.40
2020-09-30 $0.46B $0.33B 1.40
2020-06-30 $0.40B $0.30B 1.34
2020-03-31 $0.34B $0.28B 1.25
2019-12-31 $0.32B $0.29B 1.12
2019-09-30 $0.32B $0.28B 1.12
2019-06-30 $0.32B $0.28B 1.12
2019-03-31 $0.31B $0.27B 1.15
2018-12-31 $0.30B $0.28B 1.08
2018-09-30 $0.29B $0.28B 1.06
2018-06-30 $0.30B $0.27B 1.10
2018-03-31 $0.30B $0.28B 1.08
2017-12-31 $0.31B $0.28B 1.13
2017-09-30 $0.10B $0.22B 0.46
2017-06-30 $0.10B $0.22B 0.47
2017-03-31 $0.11B $0.21B 0.50
2016-12-31 $0.11B $0.21B 0.51
2016-09-30 $0.11B $0.20B 0.51
2016-06-30 $0.11B $0.20B 0.53
2016-03-31 $0.10B $0.19B 0.53
2015-12-31 $0.03B $0.16B 0.17
2015-09-30 $0.03B $0.15B 0.19
2015-06-30 $0.03B $0.15B 0.18
2015-03-31 $0.02B $0.15B 0.16
2014-12-31 $0.03B $0.15B 0.19
2014-09-30 $0.03B $0.15B 0.19
2014-06-30 $0.03B $0.15B 0.19
2014-03-31 $0.03B $0.15B 0.19
2013-12-31 $0.03B $0.15B 0.21
2013-09-30 $0.03B $0.14B 0.21
2013-06-30 $0.03B $0.13B 0.21
2013-03-31 $0.03B $0.13B 0.19
2012-12-31 $0.03B $0.13B 0.23
2012-09-30 $0.03B $0.13B 0.22
2012-06-30 $0.03B $0.12B 0.26
2012-03-31 $0.03B $0.12B 0.21
2011-12-31 $0.03B $0.12B 0.22
2011-09-30 $0.03B $0.12B 0.23
2011-06-30 $0.02B $0.12B 0.21
2011-03-31 $0.02B $0.12B 0.20
2010-12-31 $0.02B $0.11B 0.21
2010-09-30 $0.02B $0.11B 0.20
2010-06-30 $0.02B $0.12B 0.21
2010-03-31 $0.02B $0.11B 0.21
2009-12-31 $0.02B $0.11B 0.21
2009-09-30 $0.03B $0.11B 0.23
2009-06-30 $0.03B $0.11B 0.24
2009-03-31 $0.03B $0.10B 0.25
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.546B $0.299B
Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants. Artivion Inc., formerly known as CryoLife Inc., is headquartered in suburban Atlanta, Georgia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96